IART - Integra Lifesciences Holdings Corp.

IART Stock Chart

IART Profile

Integra LifeSciences Holdings Corporation, established in 1989 and headquartered in Princeton, New Jersey, specializes in the development, manufacturing, and global distribution of surgical implants and medical instruments. The company operates through two distinct segments: Codman Specialty Surgical and Tissue Technologies. Under these divisions, Integra offers a comprehensive range of products tailored for neurosurgery, including equipment for tissue ablation, dural repair, cerebral spinal fluid management, intracranial monitoring, and cranial stabilization. Its portfolio also encompasses surgical headlamps, instrumentation, asset management software, and post-sale support services.

In addition to neurosurgical innovations, Integra provides a broad array of regenerative technology and tissue repair solutions. These include products designed for acute and chronic wound treatment, hernia repair, peripheral nerve protection, and tendon repair. The company's offerings extend further into skin and wound repair, plastic and reconstructive surgery, bone grafts, and specialized nerve and tendon repair products, serving diverse medical sectors such as dental, podiatry, and veterinary practices.

Integra distributes its extensive product line through a network of direct sales teams and various distribution channels across the United States, Europe, Asia Pacific, and other international markets. Its clientele includes hospitals, integrated health networks, group purchasing organizations, surgery centers, and healthcare professionals. Through strategic partnerships and ongoing research and development efforts, Integra remains committed to advancing surgical care and enhancing patient outcomes worldwide.

With a steadfast commitment to innovation and customer satisfaction, Integra LifeSciences continues to reinforce its position as a leader in the surgical implant and medical instrument industry. By consistently introducing cutting-edge technologies and expanding its global footprint, the company aims to address evolving healthcare needs and contribute to advancements in surgical procedures and patient care.

IART Revenue Chart

IART Earnings

Analyst Ratings